Leptospira Medium Base, Korthof
To Order Contact us: lieven@wlsolutions.be
casting base |
||
| EHS3200-CAST | ea | EUR 124 |
casting base |
||
| EHS3300-CAST | ea | EUR 124 |
Tetracycline base |
||
| GA9779-100G | 100 g | EUR 150 |
Tetracycline base |
||
| GA9779-10G | 10 g | EUR 46 |
Tetracycline base |
||
| GA9779-25G | 25 g | EUR 62 |
Rimonabant base |
||
| GX9120-10MG | 10 mg | EUR 86 |
Rimonabant base |
||
| GX9120-25MG | 25 mg | EUR 130 |
Tris-base |
||
| 20-abx082498 |
|
|
Vincamine base |
||
| Q-1435.0005 | 5.0g | EUR 225 |
|
Description: Sum Formula: C21H26N2O3; CAS# [1617-90-9] |
||
Vincamine base |
||
| Q-1435.0025 | 25.0g | EUR 803 |
|
Description: Sum Formula: C21H26N2O3; CAS# [1617-90-9] |
||
ProteoIQ Base |
||
| PS2 | 1 | EUR 4262 |
Leptospira antibody |
||
| 10-1293 | 500 ug | EUR 476 |
|
Description: Mouse monoclonal Leptospira antibody |
||
Ripasudil free base |
||
| HY-15685A | 10mg | EUR 408 |
Masupirdine (free base) |
||
| HY-109118 | 1mg | EUR 223 |
R406 (free base) |
||
| HY-11108 | 10mM/1mL | EUR 231 |
ITI214 (free base) |
||
| HY-12501 | 100mg | EUR 2943 |
AS2863619 (free base) |
||
| HY-126675 | 5mg | EUR 1175 |
AZD3839 (free base) |
||
| HY-13438 | 50mg | EUR 1014 |
RPR107393 free base |
||
| HY-100299 | 1mg | EUR 481 |
FR167344 free base |
||
| HY-100301 | 1mg | EUR 2637 |
FR183998 free base |
||
| HY-100302 | 1mg | EUR 1127 |
FR194738 free base |
||
| HY-100303 | 1mg | EUR 1990 |
Vatalanib (free base) |
||
| HY-10203 | 5mg | EUR 119 |
YM158 (free base) |
||
| HY-U00355 | 1mg | EUR 2309 |
Fuchsine base (monohydrochloride) |
||
| HY-B1539A | 1g | EUR 119 |
R406(free base) |
||
| E1KS1533 | 2mg | EUR 521 |
TMB free base |
||
| TB0954 | 1g | EUR 70.88 |
Bisindolylmaleimide I base |
||
| GL2668-1MG | 1 mg | EUR 137 |
Bisindolylmaleimide I base |
||
| GL2668-5MG | 5 mg | EUR 269 |
BIX 01294 base |
||
| GL8747-1MG | 1 mg | EUR 106 |
BIX 01294 base |
||
| GL8747-25MG | 25 mg | EUR 409 |
BIX 01294 base |
||
| GL8747-5MG | 5 mg | EUR 182 |
Rhodamine B base |
||
| GT5360-100G | 100 g | EUR 158 |
Rhodamine B base |
||
| GT5360-10G | 10 g | EUR 50 |
Rhodamine B base |
||
| GT5360-25G | 25 g | EUR 70 |
Rhodamine B base |
||
| GT5360-50G | 50 g | EUR 102 |
Acridine Orange base |
||
| GT9731-25G | 25 g | EUR 166 |
Acridine Orange base |
||
| GT9731-5G | 5 g | EUR 70 |
AZD4547, Free Base |
||
| ADC-P-063 | unit | Ask for price |
AZD8055, Free Base |
||
| ADC-P-064 | unit | Ask for price |
Cyclopamine, Free Base |
||
| ADC-P-079 | unit | Ask for price |
Ixabepilone, Free Base |
||
| ADC-P-104 | unit | Ask for price |
Xylazine (free base) |
||
| Q-1445.0025 | 25.0g | EUR 321 |
|
Description: Sum Formula: C12H16N2S; CAS# [7361-61-7] |
||
R406 (free base) |
||
| A5880-100 | 100 mg | EUR 1210 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
||
R406 (free base) |
||
| A5880-25 | 25 mg | EUR 514 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
||
R406 (free base) |
||
| A5880-5 | 5 mg | EUR 166 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
||
R406 (free base) |
||
| A5880-5.1 | 10 mM (in 1mL DMSO) | EUR 264 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
||
R406 (free base) |
||
| A5880-S | Evaluation Sample | EUR 81 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
||
Rucaparib (free base) |
||
| A8893-10 | 10 mg | EUR 200 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
||
Rucaparib (free base) |
||
| A8893-200 | 200 mg | EUR 1036 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
||
Rucaparib (free base) |
||
| A8893-5 | 5 mg | EUR 137 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
||
Rucaparib (free base) |
||
| A8893-5.1 | 10 mM (in 1mL DMSO) | EUR 142 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
||
Rucaparib (free base) |
||
| A8893-50 | 50 mg | EUR 456 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
||
LY2835219 free base |
||
| A3575-100 | 100 mg | EUR 572 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
||
LY2835219 free base |
||
| A3575-25 | 25 mg | EUR 258 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
||
LY2835219 free base |
||
| A3575-5 | 5 mg | EUR 142 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
||
CETRIMIDE AGAR BASE |
||
| C03-107-10kg | 10 kg | EUR 1229 |
CETRIMIDE AGAR BASE |
||
| C03-107-2Kg | 2 Kg | EUR 306 |
CETRIMIDE AGAR BASE |
||
| C03-107-500g | 500 g | EUR 120 |
LETHEEN AGAR BASE |
||
| L12-108-10kg | 10 kg | EUR 1501 |
LETHEEN AGAR BASE |
||
| L12-108-2Kg | 2 Kg | EUR 365 |
LETHEEN AGAR BASE |
||
| L12-108-500g | 500 g | EUR 136 |
LETHEEN BROTH BASE |
||
| L12-109-10kg | 10 kg | EUR 1254 |
LETHEEN BROTH BASE |
||
| L12-109-2kg | 2kg | EUR 312 |
LETHEEN BROTH BASE |
||
| L12-109-500g | 500 g | EUR 121 |
MYCOPLASMA BROTH BASE |
||
| M13-136-10kg | 10 kg | EUR 1757 |
MYCOPLASMA BROTH BASE |
||
| M13-136-2kg | 2kg | EUR 421 |
MYCOPLASMA BROTH BASE |
||
| M13-136-500g | 500 g | EUR 151 |
Ruxolitinib (free base) |
||
| 10-042 | 25 mg | EUR 348.5 |
|
Description: Antineoplastic, anti-inflammatory and immunomodulating agent. Orally bioavailable potent ATP mimetic that inhibits both JAK1 and JAK2 with IC50 values of 2.7 and 4.5nM, respectively and is less selective for JAK3 (IC50=322nM). Affects DC differentiation and function, leading to impaired T cell activation. Used in the treatment of myeloproliferative neoplasms and psoriasis. Anticancer agent. Shown to induce apoptosis and autophagy. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro. It is investigated against the spread of the SARS-CoV-2 (COVID-19). |
||
PURPLE BROTH BASE |
||
| P16-117-10kg | 10 kg | EUR 1671 |
PURPLE BROTH BASE |
||
| P16-117-2kg | 2kg | EUR 402 |
PURPLE BROTH BASE |
||
| P16-117-500g | 500 g | EUR 146 |
MCC950 (Free base) |
||
| B1031-1 | EUR 153 | |
MCC950 (Free base) |
||
| B1031-5 | EUR 457 | |
UREA AGAR BASE |
||
| U21-102-10kg | 10 kg | EUR 1035 |
UREA AGAR BASE |
||
| U21-102-2kg | 2kg | EUR 264 |
UREA AGAR BASE |
||
| U21-102-500g | 500 g | EUR 108 |
YEAST NITROGEN BASE |
||
| Y25-104-10kg | 10 kg | EUR 5682 |
YEAST NITROGEN BASE |
||
| Y25-104-2kg | 2kg | EUR 1274 |
YEAST NITROGEN BASE |
||
| Y25-104-500g | 500 g | EUR 383 |
YP AGAR BASE |
||
| Y25-109-10kg | 10 kg | EUR 872 |
YP AGAR BASE |
||
| Y25-109-2Kg | 2 Kg | EUR 229 |
YP AGAR BASE |
||
| Y25-109-500g | 500 g | EUR 99 |
YP BASE MEDIA |
||
| Y25-110-10kg | 10 kg | EUR 899 |
YP BASE MEDIA |
||
| Y25-110-2kg | 2kg | EUR 235 |
YP BASE MEDIA |
||
| Y25-110-500g | 500 g | EUR 100 |
Apatinib (Free base) |
||
| B1613-25 | EUR 414 | |
Apatinib (Free base) |
||
| B1613-5 | EUR 142 | |
Carubicin (Free base) |
||
| B1853-1 | EUR 153 | |
Carubicin (Free base) |
||
| B1853-5 | EUR 457 | |
Anlotinib, free base |
||
| B2156-25 | EUR 588 | |
Anlotinib, free base |
||
| B2156-5 | EUR 185 | |
FIPI (free base) |
||
| B2372-25 | EUR 631 | |
FIPI (free base) |
||
| B2372-5 | EUR 196 | |
Terbinafine (Free base) |
||
| B2423-250 | EUR 207 | |
Terbinafine (Free base) |
||
| B2423-50 | EUR 120 | |